A podcast on medicine, oncology, & health policy. Host: Vinay Prasad, MD MPH from University of California San Francisco. Tweet your feedback to @Plenary_Session or e-mail plenarysessionpodcast@gmail.com
…
continue reading
Screening/ Drug efficacy/ Sotorasib/ Adaura and more由Plenary Session
…
continue reading
My UCSF lecture on driver mutation lung cancer由Plenary Session
…
continue reading
We break down the best studies from ASCO由Plenary Session
…
continue reading
Critical Appraisal - My 2 hour ASCO lecture - Day 2 version by Plenary Session由Plenary Session
…
continue reading
What you need to know in advance of ASCO由Plenary Session
…
continue reading
Should trials have carbon footprint as an endpoint?由Plenary Session
…
continue reading
My grand rounds; Beta blockers post MISingle center vs multicenter RCTMasksBoosters and more由Plenary Session
…
continue reading
I crossover SM podcast; Harvard med students video, Justice curriculum, Masking half the year由Plenary Session
…
continue reading
Patient advocates, Pharma funding, and is MRD a suitable endpoint由Plenary Session
…
continue reading
5 reasons that is a bad idea由Plenary Session
…
continue reading
Another flawed quality metric. Reviewing the NEJM paper "Beta-Blockers After Myocardial Infarction and Preserved Ejection Fraction".由Plenary Session
…
continue reading
They are shitty由Plenary Session
…
continue reading
Another flawed study Keynote 564. Pembro in adjuvant RCC由Plenary Session
…
continue reading
What happens when doctors run unethical studies?由Plenary Session
…
continue reading
Does car T cause secondary AML?We discuss由Plenary Session
…
continue reading
We talk about 2023 cancer trials由Plenary Session
…
continue reading
Goodman and I discuss ash updates.My myeloma talkhttps://www.youtube.com/watch?v=jAz84yCnfjQ由Plenary Session
…
continue reading